Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 12
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Phase II
MMC-01-09-227
NCT00231868
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
Phase II
05-402
NCT00322881
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase II
CINJ-3330
NCT00161187
Papillary Serous Carcinoma of the Endometrium
Phase II
ID00-418
NCT00515073
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer
Phase II
Vaginal Cuff Brachy
NCT00542490
Hysteroscopic Lymphatic Mapping for Endometrial Cancer
Phase II
2007-0206
NCT00671606
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
Phase II
06-685
Version April 9, 2007, NCT00483327
Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients
Phase I
06-0297
NCT00334321
Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase I
06C.549
NCT00437372
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
No phase specified
TAMC 3H04
NCT00160472
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute